These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 25915781)
1. First Crystal Structures of Mycobacterium tuberculosis 6-Oxopurine Phosphoribosyltransferase: Complexes with GMP and Pyrophosphate and with Acyclic Nucleoside Phosphonates Whose Prodrugs Have Antituberculosis Activity. Eng WS; Hocková D; Špaček P; Janeba Z; West NP; Woods K; Naesens LM; Keough DT; Guddat LW J Med Chem; 2015 Jun; 58(11):4822-38. PubMed ID: 25915781 [TBL] [Abstract][Full Text] [Related]
2. Pyrrolidine nucleoside bisphosphonates as antituberculosis agents targeting hypoxanthine-guanine phosphoribosyltransferase. Eng WS; Rejman D; Pohl R; West NP; Woods K; Naesens LMJ; Keough DT; Guddat LW Eur J Med Chem; 2018 Nov; 159():10-22. PubMed ID: 30265958 [TBL] [Abstract][Full Text] [Related]
3. Hypoxanthine-Guanine Phosphoribosyltransferase Is Dispensable for Mycobacterium smegmatis Viability. Knejzlík Z; Herkommerová K; Hocková D; Pichová I J Bacteriol; 2020 Feb; 202(5):. PubMed ID: 31818925 [TBL] [Abstract][Full Text] [Related]
4. Acyclic nucleoside phosphonates containing a second phosphonate group are potent inhibitors of 6-oxopurine phosphoribosyltransferases and have antimalarial activity. Keough DT; Špaček P; Hocková D; Tichý T; Vrbková S; Slavětínská L; Janeba Z; Naesens L; Edstein MD; Chavchich M; Wang TH; de Jersey J; Guddat LW J Med Chem; 2013 Mar; 56(6):2513-26. PubMed ID: 23448281 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of the Escherichia coli 6-oxopurine phosphoribosyltransferases by nucleoside phosphonates: potential for new antibacterial agents. Keough DT; Hocková D; Rejman D; Spaček P; Vrbková S; Krečmerová M; Eng WS; Jans H; West NP; Naesens LM; de Jersey J; Guddat LW J Med Chem; 2013 Sep; 56(17):6967-84. PubMed ID: 23927482 [TBL] [Abstract][Full Text] [Related]
7. Aza-acyclic nucleoside phosphonates containing a second phosphonate group as inhibitors of the human, Plasmodium falciparum and vivax 6-oxopurine phosphoribosyltransferases and their prodrugs as antimalarial agents. Keough DT; Hocková D; Janeba Z; Wang TH; Naesens L; Edstein MD; Chavchich M; Guddat LW J Med Chem; 2015 Jan; 58(2):827-46. PubMed ID: 25494538 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and Evaluation of Novel Acyclic Nucleoside Phosphonates as Inhibitors of Plasmodium falciparum and Human 6-Oxopurine Phosphoribosyltransferases. Kaiser MM; Hocková D; Wang TH; Dračínský M; Poštová-Slavětínská L; Procházková E; Edstein MD; Chavchich M; Keough DT; Guddat LW; Janeba Z ChemMedChem; 2015 Oct; 10(10):1707-23. PubMed ID: 26368337 [TBL] [Abstract][Full Text] [Related]
9. Antimalarial activity of prodrugs of N-branched acyclic nucleoside phosphonate inhibitors of 6-oxopurine phosphoribosyltransferases. Hocková D; Janeba Z; Naesens L; Edstein MD; Chavchich M; Keough DT; Guddat LW Bioorg Med Chem; 2015 Sep; 23(17):5502-10. PubMed ID: 26275679 [TBL] [Abstract][Full Text] [Related]
11. A prodrug approach for improving antituberculosis activity of potent Mycobacterium tuberculosis type II dehydroquinase inhibitors. Tizón L; Otero JM; Prazeres VF; Llamas-Saiz AL; Fox GC; van Raaij MJ; Lamb H; Hawkins AR; Ainsa JA; Castedo L; González-Bello C J Med Chem; 2011 Sep; 54(17):6063-84. PubMed ID: 21780742 [TBL] [Abstract][Full Text] [Related]
12. Crystal structures of Apo and GMP bound hypoxanthine-guanine phosphoribosyltransferase from Legionella pneumophila and the implications in gouty arthritis. Zhang N; Gong X; Lu M; Chen X; Qin X; Ge H J Struct Biol; 2016 Jun; 194(3):311-6. PubMed ID: 26968365 [TBL] [Abstract][Full Text] [Related]